Golf and Diabetes.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03353818 |
|
Recruitment Status : Unknown
Verified November 2017 by Alexander Christensen, University Hospital, Gentofte, Copenhagen.
Recruitment status was: Active, not recruiting
First Posted : November 27, 2017
Last Update Posted : November 27, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Type2 Diabetes | Behavioral: Golf Behavioral: No intervention | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 45 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Golf and Diabetes Can an Introctionary Course to Golf and a Free 1-year Membership in a Golf Club Increase Physichal Activity? |
| Actual Study Start Date : | May 1, 2017 |
| Estimated Primary Completion Date : | May 1, 2018 |
| Estimated Study Completion Date : | July 1, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Golf
In three different golf clubs patients will be introduced how to play golf. They will be taught techniques and recieve basic golf equipment. A total of 1 year membership free membership in the golf clubs will be given.
|
Behavioral: Golf
A free golf course and free membership for one year in a golf club will be given to participants. |
|
Placebo Comparator: Placebo
No intervention given. No restrictions on physical activity.
|
Behavioral: No intervention
Patients acting as controls will not be restricted in any ways. |
- Physical activity [ Time Frame: Evaluated at baseline and after 6 and 12 months ]Change in physical activity level from baseline to end of study evaluated by 7-days wear of accelerometers.
- Quality of life [ Time Frame: Evaluated at baseline and after 6 and 12 months ]Use of validated questionaries to evaluate impact of quality of life
- Hand muscle strength [ Time Frame: Evaluated at baseline and after 6 and 12 months ]Change in hand muscle strength
- Diabetic control [ Time Frame: Evaluated at baseline and after 6 and 12 months ]Changes in diabetes related biochemistry and cardiovascular risk factors
- Adherence [ Time Frame: Evaluated at baseline and after 6 and 12 months ]Adherence evaluated with diarries
- Estimated VO2max [ Time Frame: Evaluated at baseline and after 6 and 12 months ]Two point bicycle test, where an estimated VO2 max can be calculated
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with type 2-diabetes
- Physical activity less than 8000 steps per day
- Age > 18 years
Exclusion Criteria:
- Pregnancy
- Conditions that makes patients unfit for participation in golf
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03353818
| Denmark | |
| Department of Public Health, Research Unit and Section of General Practice, University of Aarhus, , | |
| Aarhus, Denmark | |
| Center for Diabetes Research, Gentofte Hospital | |
| Hellerup, Denmark, 2900 | |
| Responsible Party: | Alexander Christensen, MD, ph.d.-student, University Hospital, Gentofte, Copenhagen |
| ClinicalTrials.gov Identifier: | NCT03353818 |
| Other Study ID Numbers: |
H-17001697 |
| First Posted: | November 27, 2017 Key Record Dates |
| Last Update Posted: | November 27, 2017 |
| Last Verified: | November 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |

